secwatch.observer — SEC 8-K summary
======================================

Issuer:     PRECISION BIOSCIENCES INC (DTIL)
CIK:        0001357874
Form:       8-K
Filed at:   2024-05-08T23:59:59+00:00
Accession:  0000950170-24-055089
Event type: other_material
Sentiment:  positive
Materiality: 0.30
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Precision BioSciences sells 25,000 shares at $12 to management in private placement
--------------------------------------------------------------------------------

- Gross proceeds ~$300k from sale of 25,000 shares at $12.00/share (13.5% premium to prior day close).
- CEO Michael Amoroso and CFO Alex Kelly each purchase 8,334 shares ($100k); GC and CRO purchase 833 shares each.
- Net proceeds to be used to fund ongoing research and development initiatives; close expected May 8, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1357874/000095017024055089/0000950170-24-055089-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1357874/000095017024055089/dtil-20240508.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-055089

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer